The Effect of Different Types of Temporary Abdominal Closure on Intra Abdominal Hypertension.
NCT ID: NCT02229695
Last Updated: 2014-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
42 participants
OBSERVATIONAL
2014-10-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be grouped according to the method of temporarily abdominal closure (TAC) procedure:
1. Vacuum-assisted closure (VAC)
2. "Bogota bag" (BB), a sterile intravenous bag silo closure. The two methods are currently accepted with no clear cut evidence to prefer one on another. At Soroka Medical Center the decision to choose either of the methods is at the surgeon's discretion.
Intra-abdominal pressure will be measured in all patients by the urinary bladder pressure technique at 6 12 24 ant 48 hours post operation. The measurement is a routine procedure done as part of the monitoring processes of critically ill patients in the General Intensive Care Unit (GICU).
Patients will be evaluated for the development of acute intra abdominal hypertension with or without abdominal compartment syndrome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open Abdomen: Vacuum Pack Versus Sylo Bag and Mesh Protocol
NCT01864590
Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique
NCT02952976
Closed or Open Abdomen for the Management of Abdominal Sepsis
NCT03163095
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen
NCT05568238
Open Abdomen Study Comparing ABTheraâ„¢ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique
NCT01016353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Trial objective:
To investigate and compare in a standardized manner the development of intra-abdominal hypertension (IAH) following VAC closure and "Bogota bag".
Study design:
This is a prospective comparison trial. Patients that will be included in the trial are those that will have operations in which their abdominal closure is temporary, i.e. patients sustaining trauma or septic abdomen.
Patients will be grouped according to the method of temporarily abdominal closure (TAC) procedure:
1. VAC closure
2. "Bogota bag" (BB), a sterile intravenous bag silo closure. The two methods are currently accepted with no clear cut evidence to prefer one on another. At Soroka Medical Center the decision to choose either of the methods is at the surgeon's discretion.
Intra-abdominal pressure will be measured in all patients by the urinary bladder pressure technique at 6 12 24 ant 48 hours post operation. The measurement is a routine procedure done as part of the monitoring processes of critically ill patients in the GICU. It will be carried out by a nurse who will be blinded as to the type of the abdominal closure.
Patients will be evaluated for the development of acute and significant respiratory compromise, including an elevated inspiratory pressure of \>35 mbar and a decreased partial oxygen pressure / fraction of inspired oxygen (PaO2/FIO2) of \<150 torr, hypotension (\<90 mmHg systolic pressure not due to hemorrhagic, septic, or neurogenic causes), renal dysfunction (urine output, \<30 mL/hr), and a clinically determined rigid, tense abdomen, and increased abdominal circumference.
The following data will be recorded. Hemodynamics (mean arterial pressure, heart rate), lactate, PaO2, partial carbonic dioxide pressure (PaCO2), tidal volume, peak airway pressure) and renal (urine output) functions will be registered at 24 and 48 hours following surgery).
Data on the indication for operation, type of trauma, its severity and the operative procedures.
Acute Physiologic and Chronic Health Evaluation II (APACHE II) and fluid balance at 24 and 48 hours.
Reoperations. Time in ICU and time to final abdominal closure.
Study population:
All patients with severe abdominal trauma or none traumatic acute abdomen, that at the end of operation the surgeon will decide to use temporary abdominal closure (TAC).
Inclusion Criteria Adults male or female over 18 years old. The surgeon decides the need for TAC at the end of operation.
Exclusion Criteria Patients that the surgeon estimates they will not survive 24 hours.
End points:
Development of IAH Development of abdominal compartment syndrome (ACS) Need for reoperation of decompressive laparotomy during first 48 hours. Time to final (on discharge from hospital) abdominal closure and the type of closure.
Statistical methodology The calculated sample size based on power of 0.80, alpha 0.05, known incidence of 0.25 and estimated incidence of 0.10 is 42 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soroka University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gad Shaked MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gad Shaked, Prof.
Role: PRINCIPAL_INVESTIGATOR
Soroka University Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SOR-0167-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.